This page contains affiliate links. We may earn a commission at no extra cost to you.

$10–$25 for a 90-180 day supply

Check Price on Amazon
Evidence: Moderate — strong epidemiological association between deficiency and neuropathic pain. Multiple small positive RCTs showing pain reduction with vitamin D repletion. Deficiency correction is broadly recommended by integrative and functional medicine practitioners for neuropathy patients.

Vitamin D — properly a steroid hormone precursor rather than a vitamin — plays a broad role in immune regulation, inflammation control, and nerve function that extends well beyond its classical role in calcium metabolism and bone health. Vitamin D deficiency is highly prevalent in the general population (estimated 40% of American adults) and significantly more prevalent among people with chronic pain conditions including peripheral neuropathy. Multiple epidemiological studies have found associations between low vitamin D levels and neuropathic pain severity, and several small intervention trials have shown that correcting vitamin D deficiency reduces neuropathic pain scores. Vitamin D supplementation is safe, inexpensive, and easy to test for deficiency — making it one of the first things to assess and address in any neuropathy patient. Discuss with your physician before starting, as excessive vitamin D can cause toxicity.

How It Works

Vitamin D3 (cholecalciferol) is synthesized in the skin under UV-B light exposure and converted in the liver to 25-hydroxyvitamin D (the storage form measured in blood tests) and then in the kidneys to the active form 1,25-dihydroxyvitamin D (calcitriol). Calcitriol acts on vitamin D receptors (VDRs) found throughout the body — including peripheral nerve fibers, Schwann cells, dorsal root ganglia neurons, and immune cells.

In the context of peripheral neuropathy, vitamin D’s relevant mechanisms include: modulation of inflammatory cytokine production (reducing IL-1β, TNF-α, IL-6 — all of which contribute to neuropathic sensitization), direct support of nerve fiber survival and Schwann cell function, regulation of neurotrophic factors including nerve growth factor (NGF), and modulation of pain transmission in the dorsal horn of the spinal cord. Some research also suggests vitamin D deficiency impairs the immune regulation that keeps autoimmune neuropathy in check.

The Deficiency-Neuropathy Connection

Several studies have documented higher rates of vitamin D deficiency in neuropathy patients compared to controls. A 2017 study in the Journal of the Neurological Sciences found that patients with idiopathic peripheral neuropathy had significantly lower 25(OH)D levels than healthy controls, and that neuropathic pain severity was inversely correlated with vitamin D status — the lower the vitamin D, the worse the pain. Similar associations have been reported in diabetic neuropathy, with some studies finding that vitamin D deficiency predicts neuropathy development in diabetic patients independent of glycemic control.

A 2015 RCT published in Neuropathy Research found that patients with painful diabetic neuropathy who received 50,000 IU of vitamin D2 weekly for 3 months showed significant reductions in pain VAS scores compared to placebo. A 2012 randomized trial in patients with chronic pain and vitamin D deficiency found that vitamin D supplementation produced sustained pain reduction at 6 months. While not all trials show effect, the pattern of evidence — combined with the safety of correcting a deficiency — justifies prioritizing vitamin D testing and repletion in all neuropathy patients.

Testing and Monitoring

Vitamin D status is assessed with a 25-hydroxyvitamin D (25(OH)D) blood test — ask your physician to include this in your neuropathy workup if it has not been checked. The test is inexpensive and widely available. Standard reference ranges define deficiency as below 20 ng/mL and insufficiency as 20–29 ng/mL. For chronic pain and neuropathy purposes, many clinicians target levels of 40–60 ng/mL, as this appears to be the range associated with optimal nerve function in observational data.

After starting supplementation, recheck the 25(OH)D level at 3 months to confirm adequate repletion — individual absorption and conversion vary significantly. People with obesity, malabsorption conditions (Crohn’s disease, celiac disease, bypass surgery), and darker skin pigmentation often require higher doses to achieve target levels. Vitamin K2 is commonly co-supplemented with higher-dose vitamin D3 (above 2,000 IU/day) to support appropriate calcium metabolism — discuss with your physician.

Safety and Toxicity

Vitamin D toxicity (hypervitaminosis D) is rare at doses below 10,000 IU per day in adults without underlying conditions affecting calcium metabolism. Symptoms of toxicity include nausea, weakness, frequent urination, and in severe cases, kidney damage from hypercalcemia. The safety window for vitamin D is broad — the Institute of Medicine’s tolerable upper limit is 4,000 IU/day, though most clinical practitioners use doses of 5,000–10,000 IU/day under physician supervision without issue when blood levels are monitored.

Patients with sarcoidosis, hyperparathyroidism, or other conditions that increase sensitivity to vitamin D should not supplement without physician guidance. Thiazide diuretics (used for blood pressure) increase renal calcium reabsorption and may increase hypercalcemia risk with high-dose vitamin D.

Pros

• One of the simplest and safest interventions to address in neuropathy — test and correct
• Strong epidemiological association with neuropathic pain; small RCTs show benefit
• Inexpensive supplementation — significant value relative to more costly interventions
• Broad health benefits beyond neuropathy — immune function, bone health, cardiovascular
• Easy to monitor blood levels and adjust dose to achieve target range

Cons

• Benefit primarily in patients with documented deficiency — less evidence for pain reduction in replete patients
• Toxicity possible at very high doses without monitoring
• Effect size modest compared to first-line neuropathy medications in available trials
• Not a substitute for comprehensive neuropathy management

Frequently Asked Questions

Should every neuropathy patient check their vitamin D level?

Yes — vitamin D deficiency testing is among the first blood tests ordered in a standard neuropathy workup, and for good reason. Given its prevalence, safety of correction, and evidence for association with neuropathic pain, identifying and correcting vitamin D deficiency is one of the most accessible and low-risk interventions available to neuropathy patients. If your physician has not checked your vitamin D level, ask them to add it to your next blood panel.

How much vitamin D should I take for neuropathy?

Dosing should be based on your measured 25(OH)D level, not a fixed universal dose. For documented deficiency (below 20 ng/mL), physician-supervised repletion may use 5,000–10,000 IU/day for 8 to 12 weeks, followed by a maintenance dose of 1,000–2,000 IU/day. Do not self-prescribe high doses without measuring your baseline level and rechecking after supplementation. The appropriate dose varies significantly by individual.

Can vitamin D replace my neuropathy medications?

No. Vitamin D supplementation addresses a potential contributing factor to neuropathic pain — it is an adjunct to, not a replacement for, evidence-based neuropathy management. Patients who achieve significant pain reduction with vitamin D repletion alone typically had significant deficiency as a contributing factor. For most patients, vitamin D is one component of a multi-pronged management approach.

Buy on Amazon — $10–$25 for a 90-180 day supply